Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pectasides

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
American Journal of Clinical Oncology|August 1, 1994
Squamous cell carcinoma antigen, tumor-associated trypsin inhibitor, and carcinoembryonic antigen for monitoring cervical cancerD Pectasides, N Economides, J Bourazanis, et al.
American Journal of Clinical Oncology|December 1, 1991
Correlation of abdominal computed tomography scanning and second-look operation findings in ovarian cancer patientsD Pectasides, H Kayianni, A Facou, et al.
Anticancer Research|July 1, 1990
131I-labelled monoclonal antibody H17E2 in the detection of subcutaneous metastasis from gestational choriocarcinomaA Athanassiou, D Pectasides, K Pateniotis, et al.
Oncology|April 29, 1998
Paclitaxel in cisplatin or carboplatin-pretreated ovarian cancer. Phase II studyD Pectasides, M Papadopoulou, J Varthalitis, et al.
The International Journal of Biological Markers|April 1, 1993
Squamous cell carcinoma antigen (SCC), carcinoembryonic antigen (CEA), and tumour-associated trypsin inhibitor (TATI) for monitoring head and neck cancerD Pectasides, J Bourazanis, N Economides, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trialD Pectasides, A Visvikis, A Aspropotamitis, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 9, 2007
Successful management of extracranial metastases from cerebral high-grade oligodendroglioma: report of a case with literature reviewD Pectasides, A Halikia, A Visvikis, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2002
Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II studyD Pectasides, A Visvikis, A Kouloubinis, et al.
British Journal of Cancer|October 1, 1989
Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatinD Pectasides, H Yianniotis, N Alevizakos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II studyD Pectasides, M Pectasides, D Farmakis, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
American Journal of Clinical Oncology|August 1, 1994
Squamous cell carcinoma antigen, tumor-associated trypsin inhibitor, and carcinoembryonic antigen for monitoring cervical cancerD Pectasides, N Economides, J Bourazanis, et al.
American Journal of Clinical Oncology|December 1, 1991
Correlation of abdominal computed tomography scanning and second-look operation findings in ovarian cancer patientsD Pectasides, H Kayianni, A Facou, et al.
Anticancer Research|July 1, 1990
131I-labelled monoclonal antibody H17E2 in the detection of subcutaneous metastasis from gestational choriocarcinomaA Athanassiou, D Pectasides, K Pateniotis, et al.
Oncology|April 29, 1998
Paclitaxel in cisplatin or carboplatin-pretreated ovarian cancer. Phase II studyD Pectasides, M Papadopoulou, J Varthalitis, et al.
The International Journal of Biological Markers|April 1, 1993
Squamous cell carcinoma antigen (SCC), carcinoembryonic antigen (CEA), and tumour-associated trypsin inhibitor (TATI) for monitoring head and neck cancerD Pectasides, J Bourazanis, N Economides, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trialD Pectasides, A Visvikis, A Aspropotamitis, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 9, 2007
Successful management of extracranial metastases from cerebral high-grade oligodendroglioma: report of a case with literature reviewD Pectasides, A Halikia, A Visvikis, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2002
Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II studyD Pectasides, A Visvikis, A Kouloubinis, et al.
British Journal of Cancer|October 1, 1989
Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatinD Pectasides, H Yianniotis, N Alevizakos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II studyD Pectasides, M Pectasides, D Farmakis, et al.
Pageof 13